APO Research
Talk to an analyst

APO RESEARCH · REPORT

Chinese Medicine Testing

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Chinese Medicine Testing Market Outlook and Growth Opportunities 2026

30 January 2026191 pages

Choose your research edition.

Industry ResearchChinese Medicine Testing Industry Research Report 2026113 pages · $2,950 USDIndustry Growth & TrendsGlobal Chinese Medicine Testing Industry Growth and Trends Forecast to 203289 pages · $3,450 USDMarket StructureGlobal Chinese Medicine Testing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Chinese Medicine Testing Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Chinese Medicine Testing Market Analysis and Forecast 2026-2032190 pages · $4,950 USD

Market perspective

The global Chinese Medicine Testing market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Chinese Medicine Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Chinese Medicine Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Chinese Medicine Testing is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Chinese Medicine Testing market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Chinese Medicine Testing market include Castco Testing Centre, Hong Kong Productivity Council (HKPC), SGS, Lab Test One, CMA Testing, Agilent Technologies, Hong Kong Standards and Testing Centre and Nuherbs, among others. In 2025, the top three vendors together accounted for approximately % of global market revenue.

This report provides an overview of the global Chinese Medicine Testing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Chinese Medicine Testing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Chinese Medicine Testing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Chinese Medicine Testing market.

Chinese Medicine Testing Segment by Company

Castco Testing Centre

Hong Kong Productivity Council (HKPC)

SGS

Lab Test One

CMA Testing

Agilent Technologies

Hong Kong Standards and Testing Centre

Nuherbs

Chinese Medicine Testing Segment by Type

Chinese Herbal Medicine

Chinese Patent Medicine

Chinese Medicine Testing Segment by Application

Laboratory

Factory

Chinese Medicine Testing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Chinese Medicine Testing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Chinese Medicine Testing key companies, revenue, market share, and recent developments.

3. To split the Chinese Medicine Testing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Chinese Medicine Testing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Chinese Medicine Testing significant trends, drivers, influence factors in global and regions.

6. To analyze Chinese Medicine Testing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Chinese Medicine Testing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Chinese Medicine Testing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Chinese Medicine Testing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Chinese Medicine Testing industry.

Chapter 3: Detailed analysis of Chinese Medicine Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Chinese Medicine Testing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Chinese Medicine Testing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Chinese Medicine Testing Industry Trends Table 2. Chinese Medicine Testing Industry Drivers Table 3. Chinese Medicine Testing Industry Opportunities and Challenges Table 4. Chinese Medicine Testing Industry Restraints Table 5. Global Chinese Medicine Testing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Chinese Medicine Testing Revenue Share by Company (2021-2026) Table 7. Global Chinese Medicine Testing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Chinese Medicine Testing Key Company Manufacturing Base & Headquarters Table 9. Global Chinese Medicine Testing Company, Product Type & Application Table 10. Global Chinese Medicine Testing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Chinese Medicine Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Chinese Herbal Medicine Table 15. Significant Companies of Chinese Patent Medicine Table 16. Global Chinese Medicine Testing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Chinese Medicine Testing Sales Value by Type (2021-2026) & (US$ Million) Table 18. Global Chinese Medicine Testing Sales Value by Type (2027-2032) & (US$ Million) Table 19. Global Chinese Medicine Testing Sales Value Share by Type (2021-2026) Table 20. Global Chinese Medicine Testing Sales Value Share by Type (2027-2032) Table 21. Significant Companies of Laboratory Table 22. Significant Companies of Factory Table 23. Global Chinese Medicine Testing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 24. Global Chinese Medicine Testing Sales Value by Application (2021-2026) & (US$ Million) Table 25. Global Chinese Medicine Testing Sales Value by Application (2027-2032) & (US$ Million) Table 26. Global Chinese Medicine Testing Sales Value Share by Application (2021-2026) Table 27. Global Chinese Medicine Testing Sales Value Share by Application (2027-2032) Table 28. Global Chinese Medicine Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 29. Global Chinese Medicine Testing Sales Value by Region (2021-2026) & (US$ Million) Table 30. Global Chinese Medicine Testing Sales Value Share by Region (2021-2026) Table 31. Global Chinese Medicine Testing Sales Value by Region (2027-2032) & (US$ Million) Table 32. Global Chinese Medicine Testing Sales Value Share by Region (2027-2032) Table 33. Global Chinese Medicine Testing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Chinese Medicine Testing Sales Value by Country (2021-2026) & (US$ Million) Table 35. Global Chinese Medicine Testing Sales Value Market Share by Country (2021-2026) Table 36. Global Chinese Medicine Testing Sales Value by Country (2027-2032) & (US$ Million) Table 37. Global Chinese Medicine Testing Sales Value Market Share by Country (2027-2032) Table 38. Castco Testing Centre Company Information Table 39. Castco Testing Centre Business Overview Table 40. Castco Testing Centre Chinese Medicine Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 41. Castco Testing Centre Chinese Medicine Testing Product Portfolio Table 42. Castco Testing Centre Recent Development Table 43. Hong Kong Productivity Council (HKPC) Company Information Table 44. Hong Kong Productivity Council (HKPC) Business Overview Table 45. Hong Kong Productivity Council (HKPC) Chinese Medicine Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 46. Hong Kong Productivity Council (HKPC) Chinese Medicine Testing Product Portfolio Table 47. Hong Kong Productivity Council (HKPC) Recent Development Table 48. SGS Company Information Table 49. SGS Business Overview Table 50. SGS Chinese Medicine Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 51. SGS Chinese Medicine Testing Product Portfolio Table 52. SGS Recent Development Table 53. Lab Test One Company Information Table 54. Lab Test One Business Overview Table 55. Lab Test One Chinese Medicine Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 56. Lab Test One Chinese Medicine Testing Product Portfolio Table 57. Lab Test One Recent Development Table 58. CMA Testing Company Information Table 59. CMA Testing Business Overview Table 60. CMA Testing Chinese Medicine Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 61. CMA Testing Chinese Medicine Testing Product Portfolio Table 62. CMA Testing Recent Development Table 63. Agilent Technologies Company Information Table 64. Agilent Technologies Business Overview Table 65. Agilent Technologies Chinese Medicine Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Agilent Technologies Chinese Medicine Testing Product Portfolio Table 67. Agilent Technologies Recent Development Table 68. Hong Kong Standards and Testing Centre Company Information Table 69. Hong Kong Standards and Testing Centre Business Overview Table 70. Hong Kong Standards and Testing Centre Chinese Medicine Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Hong Kong Standards and Testing Centre Chinese Medicine Testing Product Portfolio Table 72. Hong Kong Standards and Testing Centre Recent Development Table 73. Nuherbs Company Information Table 74. Nuherbs Business Overview Table 75. Nuherbs Chinese Medicine Testing Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Nuherbs Chinese Medicine Testing Product Portfolio Table 77. Nuherbs Recent Development Table 78. Research Programs/Design for This Report Table 79. Authors List of This Report Table 80. Secondary Sources Table 81. Primary Sources List of Figures Figure 1. Chinese Medicine Testing Product Image Figure 2. Global Chinese Medicine Testing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Chinese Medicine Testing Market Size (2021-2032) & (US$ Million) Figure 4. Global Chinese Medicine Testing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Chinese Herbal Medicine Image Figure 8. Chinese Patent Medicine Image Figure 9. Global Chinese Medicine Testing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 10. Global Chinese Medicine Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 11. Global Chinese Medicine Testing Sales Value Share by Type (2021-2032) Figure 12. Laboratory Image Figure 13. Factory Image Figure 14. Global Chinese Medicine Testing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Chinese Medicine Testing Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Chinese Medicine Testing Sales Value Share by Application (2021-2032) Figure 17. Global Chinese Medicine Testing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Chinese Medicine Testing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 19. North America Chinese Medicine Testing Sales Value (2021-2032) & (US$ Million) Figure 20. North America Chinese Medicine Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 21. Europe Chinese Medicine Testing Sales Value (2021-2032) & (US$ Million) Figure 22. Europe Chinese Medicine Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 23. Asia-Pacific Chinese Medicine Testing Sales Value (2021-2032) & (US$ Million) Figure 24. Asia-Pacific Chinese Medicine Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 25. South America Chinese Medicine Testing Sales Value (2021-2032) & (US$ Million) Figure 26. South America Chinese Medicine Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Middle East & Africa Chinese Medicine Testing Sales Value (2021-2032) & (US$ Million) Figure 28. Middle East & Africa Chinese Medicine Testing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. USA Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 30. USA Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 31. USA Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 32. Canada Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 33. Canada Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 34. Canada Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 35. Mexico Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. Mexico Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. Mexico Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Germany Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Germany Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Germany Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. France Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. France Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. France Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. U.K. Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. U.K. Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. U.K. Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Italy Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Italy Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Italy Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Spain Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Spain Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Spain Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Russia Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Russia Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Russia Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Netherlands Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Netherlands Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Netherlands Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Nordic Countries Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Nordic Countries Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Nordic Countries Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. China Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. China Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. China Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Japan Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Japan Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Japan Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. South Korea Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. South Korea Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. South Korea Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. India Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. India Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. India Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. Australia Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. Australia Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. Australia Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Southeast Asia Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Southeast Asia Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Southeast Asia Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Brazil Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Brazil Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Brazil Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Argentina Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Argentina Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Argentina Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Chile Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Chile Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Chile Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Colombia Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Colombia Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Colombia Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Peru Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Peru Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Peru Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Saudi Arabia Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Saudi Arabia Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Saudi Arabia Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Israel Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Israel Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Israel Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. UAE Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. UAE Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. UAE Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Turkey Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Turkey Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Turkey Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Iran Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Iran Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Iran Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Egypt Chinese Medicine Testing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Egypt Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Egypt Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Years Considered Figure 114. Research Process Figure 115. Key Executives Interviewed

Scope & coverage.

Types
  • Chinese Herbal Medicine
  • Chinese Patent Medicine
Applications
  • Laboratory
  • Factory
Companies covered
  • Castco Testing Centre
  • Hong Kong Productivity Council (HKPC)
  • SGS
  • Lab Test One
  • CMA Testing
  • Agilent Technologies
  • Hong Kong Standards and Testing Centre
  • Nuherbs

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Chinese Medicine Testing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Chinese Medicine Testing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Chinese Medicine Testing Market Dynamics
  1. 2.1 Chinese Medicine Testing Industry Trends
  2. 2.2 Chinese Medicine Testing Industry Drivers
  3. 2.3 Chinese Medicine Testing Industry Opportunities and Challenges
  4. 2.4 Chinese Medicine Testing Industry Restraints
3 Chinese Medicine Testing Market by Company
  1. 3.1 Global Chinese Medicine Testing Company Revenue Ranking in 2025
  2. 3.2 Global Chinese Medicine Testing Revenue by Company (2021-2026)
  3. 3.3 Global Chinese Medicine Testing Company Ranking (2024-2026)
  4. 3.4 Global Chinese Medicine Testing Company Manufacturing Base and Headquarters
  5. 3.5 Global Chinese Medicine Testing Company Product Type and Application
  6. 3.6 Global Chinese Medicine Testing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Chinese Medicine Testing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Chinese Medicine Testing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Chinese Medicine Testing Market by Type
  1. 4.1 Chinese Medicine Testing Type Introduction
  2. 4.1.1 Chinese Herbal Medicine
  3. 4.1.2 Chinese Patent Medicine
  4. 4.2 Global Chinese Medicine Testing Sales Value by Type
  5. 4.2.1 Global Chinese Medicine Testing Sales Value by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Chinese Medicine Testing Sales Value by Type (2021-2032)
  7. 4.2.3 Global Chinese Medicine Testing Sales Value Share by Type (2021-2032)
5 Chinese Medicine Testing Market by Application
  1. 5.1 Chinese Medicine Testing Application Introduction
  2. 5.1.1 Laboratory
  3. 5.1.2 Factory
  4. 5.2 Global Chinese Medicine Testing Sales Value by Application
  5. 5.2.1 Global Chinese Medicine Testing Sales Value by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Chinese Medicine Testing Sales Value by Application (2021-2032)
  7. 5.2.3 Global Chinese Medicine Testing Sales Value Share by Application (2021-2032)
6 Chinese Medicine Testing Regional Value Analysis
  1. 6.1 Global Chinese Medicine Testing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Chinese Medicine Testing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Chinese Medicine Testing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Chinese Medicine Testing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Chinese Medicine Testing Sales Value (2021-2032)
  7. 6.3.2 North America Chinese Medicine Testing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Chinese Medicine Testing Sales Value (2021-2032)
  10. 6.4.2 Europe Chinese Medicine Testing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Chinese Medicine Testing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Chinese Medicine Testing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Chinese Medicine Testing Sales Value (2021-2032)
  16. 6.6.2 South America Chinese Medicine Testing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Chinese Medicine Testing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Chinese Medicine Testing Sales Value Share by Country, 2025 VS 2032
7 Chinese Medicine Testing Country-level Value Analysis
  1. 7.1 Global Chinese Medicine Testing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Chinese Medicine Testing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Chinese Medicine Testing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Chinese Medicine Testing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Chinese Medicine Testing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Chinese Medicine Testing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Chinese Medicine Testing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Castco Testing Centre
  2. 8.1.1 Castco Testing Centre Company Information
  3. 8.1.2 Castco Testing Centre Business Overview
  4. 8.1.3 Castco Testing Centre Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Castco Testing Centre Chinese Medicine Testing Product Portfolio
  6. 8.1.5 Castco Testing Centre Recent Developments
  7. 8.2 Hong Kong Productivity Council (HKPC)
  8. 8.2.1 Hong Kong Productivity Council (HKPC) Company Information
  9. 8.2.2 Hong Kong Productivity Council (HKPC) Business Overview
  10. 8.2.3 Hong Kong Productivity Council (HKPC) Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Hong Kong Productivity Council (HKPC) Chinese Medicine Testing Product Portfolio
  12. 8.2.5 Hong Kong Productivity Council (HKPC) Recent Developments
  13. 8.3 SGS
  14. 8.3.1 SGS Company Information
  15. 8.3.2 SGS Business Overview
  16. 8.3.3 SGS Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 SGS Chinese Medicine Testing Product Portfolio
  18. 8.3.5 SGS Recent Developments
  19. 8.4 Lab Test One
  20. 8.4.1 Lab Test One Company Information
  21. 8.4.2 Lab Test One Business Overview
  22. 8.4.3 Lab Test One Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Lab Test One Chinese Medicine Testing Product Portfolio
  24. 8.4.5 Lab Test One Recent Developments
  25. 8.5 CMA Testing
  26. 8.5.1 CMA Testing Company Information
  27. 8.5.2 CMA Testing Business Overview
  28. 8.5.3 CMA Testing Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 CMA Testing Chinese Medicine Testing Product Portfolio
  30. 8.5.5 CMA Testing Recent Developments
  31. 8.6 Agilent Technologies
  32. 8.6.1 Agilent Technologies Company Information
  33. 8.6.2 Agilent Technologies Business Overview
  34. 8.6.3 Agilent Technologies Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Agilent Technologies Chinese Medicine Testing Product Portfolio
  36. 8.6.5 Agilent Technologies Recent Developments
  37. 8.7 Hong Kong Standards and Testing Centre
  38. 8.7.1 Hong Kong Standards and Testing Centre Company Information
  39. 8.7.2 Hong Kong Standards and Testing Centre Business Overview
  40. 8.7.3 Hong Kong Standards and Testing Centre Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Hong Kong Standards and Testing Centre Chinese Medicine Testing Product Portfolio
  42. 8.7.5 Hong Kong Standards and Testing Centre Recent Developments
  43. 8.8 Nuherbs
  44. 8.8.1 Nuherbs Company Information
  45. 8.8.2 Nuherbs Business Overview
  46. 8.8.3 Nuherbs Chinese Medicine Testing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Nuherbs Chinese Medicine Testing Product Portfolio
  48. 8.8.5 Nuherbs Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst